Health ❯Healthcare

Vaccine Technology

Protein-based Vaccines Traditional Vaccines

HHS Terminates Nearly $600 Million Moderna Contract for Bird Flu Vaccine

By citing under-tested mRNA safety concerns, HHS shifted focus away from the pre-pandemic H5N1 vaccine effort

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach

FDA Halts Novavax's COVID-Flu Combo Vaccine Trial Over Safety Concerns